Compare Globus Medical Inc. Class A Common Stock (GMED) vs Howmet Aerospace Inc (HWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Howmet Aerospace Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Howmet Aerospace Inc trades at $217.44 (market cap $86.48B). The key difference: Howmet Aerospace Inc is far larger — about 8.4× Globus Medical Inc. Class A Common Stock's market cap, and Howmet Aerospace Inc pays a 0.26% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Howmet Aerospace Inc for 35 Days on average.
| GMED | HWM | |
|---|---|---|
Market Cap | $10.25B | $86.48B |
Volume | 1,108,124 | 3,558,498 |
Sector | Health | Industrials |
52-Week High | $96.82 | $292.65 |
52-Week Low | $58.33 | $189.68 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $9.76B | $90.58B |
Dividend Yield | — | 0.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Howmet Aerospace (HWM) trades at $216.84, down 1.8% with bearish technical signals despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters with Q2 2026 EPS of $1.33 exceeding expectations. Revenue growth continues with 2026 projections showing $9.1B revenue and 20.52% net margin. Analyst consensus remains strongly bullish with 84% buy ratings and $328.10 price target representing 51% upside potential.
The stock presents compelling growth potential driven by aerospace demand and defense modernization trends, though technical weakness and valuation concerns at 46.7x P/E warrant caution. Strong cash flow generation supports shareholder returns including dividends and buybacks, while supply chain risks and competitive pressures remain key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →
